コンテンツへスキップ
· スキンブースター
SKU 11122

Aquashine HA

In stock
Volume
1 x 2 mL
Laboratory
Caregen Co., Ltd.
Origin
韓国
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

Aquashine HA is a sterile injectable intradermal implant manufactured by Caregen Co., Ltd. in South Korea, based on cross-linked hyaluronic acid and designed to smooth wrinkles and folds. Placed in the middle and superficial dermis, the gel binds water in the tissue to restore dermal density and the facial oval and to provide deep hydration. Its sodium hyaluronate is of non-animal, biosynthetic origin and is cross-linked with BDDE, with residual BDDE below 1 ppm. The implant is CE-marked and supplied for professional use by appropriately trained practitioners only.

*Note: The manufacturer does not currently list this reference on their website. Please confirm current availability with ALLPARA before purchasing.

主なメリット: Aquashine HA

  • Cross-linked hyaluronic acid at 15 mg/ml (sodium hyaluronate), of non-animal biosynthetic origin
  • Placed in the middle and superficial dermis to restore dermal density and smooth wrinkles and folds
  • Restores the skin's hydrobalance and supports lifting and restoration of the facial oval
  • Suited to the nasolabial and oral-chin folds, chin and cheekbones
  • Supplied as a 3 ml syringe filled with 2 ml of gel, with two sterile 30G 13 mm needles
  • Manufactured by Caregen Co., Ltd. (South Korea); CE-marked, single use only
主な情報
ブランド AQUASHINE
製造元 Caregen Co., Ltd.
原産国 South Korea
認証 CE marked (per MDD 93/42/EEC)
成分 Cross-linked sodium hyaluronate 15 mg/ml (1.5%); sodium chloride 6.1 mg/ml; sodium hydroxide 2.7 mg/ml; monosodium phosphate 0.8 mg/ml; disodium phosphate 1.4 mg/ml; sodium bisulfate monohydrate 1.9 mg/ml; 1,4-butanediol diglycidyl ether (BDDE) 0.000021 mg/ml (residual below 1 ppm); protein 0.00046 mg/ml; water for injection to 1.0 ml
容量 / サイズ 2 ml
包装 1 x 2 mL
針のサイズ 30G (0.30 x 13 mm)
使用タイプ For professional use: intradermal hyaluronic acid implant, administered only by qualified practitioners trained in injection technique
注入の深さ Middle and superficial dermis
プロトコル / 期間 Usually one treatment course, occasionally two; aesthetic effect retained 1 to 6 months

適応と専門的な使用

主な適応

  • Correction of wrinkles and folds of the facial tissues
  • Restoration and modelling of volume, and replenishment of missing tissue volume
  • Restoration of the skin's hydrobalance and tissue structure
  • Correction of the shape and volume of the lips, cheekbones and facial oval
  • Rejuvenation of the hands
  • Hydration and rejuvenation of the skin

専門的な使用

Aquashine HA is intended for administration only by qualified medical personnel trained in intradermal injection technique, using aseptic technique. It is placed in the middle and superficial dermis using the supplied 30G (0.30 x 13 mm) needle, by linear (threading), linear-point, point or grid technique. It must not be combined with implants or gels from other manufacturers in a single procedure; injection into the eyelids and intravascular injection are strictly prohibited. Single use, one patient only; do not re-sterilise. Patient selection, injection technique and aftercare remain the responsibility of the treating practitioner.

施術部位

  • Nasolabial folds
  • Oral-chin (labiomental) folds
  • Chin
  • Cheekbones

対象となる患者

Suitable for adult patients seeking correction of wrinkles and folds, restoration of hydrobalance and dermal structure, and rejuvenation of the skin, as assessed by a qualified practitioner. Contraindicated in pregnancy and lactation, allergy to any component, systemic retinoid, anticoagulant/antithrombotic or immunosuppressive therapy, inflammatory infiltrates, progressive chronic dermatoses, herpetic infection, paraneoplastic processes at the injection site, and decompensated severe somatic disease. In patients under 18, only with the consent of a legal representative.

作用の仕組み: Aquashine HA ​

Aquashine HA is a cross-linked hyaluronic acid gel at 15 mg/ml of sodium hyaluronate in a phosphate buffer. Placed in the middle and superficial dermis, the cross-linked hyaluronic acid binds water in the tissue, so the effect is restored moisture, improved dermal density and smoothing of wrinkles and folds rather than deep volumising. Full resorption occurs at approximately one month, with the aesthetic effect retained from one to six months depending on the skin, the wrinkle and the technique used.

Allparaで注文する理由

Allparaは、正規品で検証済みの AQUASHINE 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。

よくある質問

What is in Aquashine HA?

Cross-linked sodium hyaluronate at 15 mg/ml in a phosphate buffer, of non-animal biosynthetic origin, cross-linked with BDDE (residual BDDE below 1 ppm).

Where is Aquashine HA injected?

Into the middle and superficial dermis, using the supplied 30G 13 mm needle. It is directed at the nasolabial and oral-chin folds, the chin and the cheekbones.

How does Aquashine HA differ from Aquashine HA BR?

Aquashine HA is the 15 mg/ml, medium-viscosity variant (25.0 Pa·s), directed at the nasolabial and oral-chin folds, the chin and the cheekbones. Aquashine HA BR is the 13 mg/ml, lower-viscosity variant (18.0 Pa·s), directed at the periorbital zone, neck, lips and forehead.

その他の製品: Caregen

View laboratory

Clinic alternatives

All products
Jalupro HMW
Jalupro HMW バイオリバイタライゼーション
Jalupro Super Hydro
Jalupro Super Hydro バイオリバイタライゼーション
Plinest
Plinest バイオリバイタライゼーション

Aquashine HA

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

Aquashine HA is a sterile injectable intradermal implant manufactured by Caregen Co., Ltd. in South Korea, based on cross-linked hyaluronic acid and designed to smooth wrinkles and folds. Placed in the middle and superficial dermis, the gel binds water in the tissue to restore dermal density and the facial oval and to provide deep hydration. Its sodium hyaluronate is of non-animal, biosynthetic origin and is cross-linked with BDDE, with residual BDDE below 1 ppm. The implant is CE-marked and supplied for professional use by appropriately trained practitioners only.

*Note: The manufacturer does not currently list this reference on their website. Please confirm current availability with ALLPARA before purchasing.

主なメリット: Aquashine HA

  • Cross-linked hyaluronic acid at 15 mg/ml (sodium hyaluronate), of non-animal biosynthetic origin
  • Placed in the middle and superficial dermis to restore dermal density and smooth wrinkles and folds
  • Restores the skin's hydrobalance and supports lifting and restoration of the facial oval
  • Suited to the nasolabial and oral-chin folds, chin and cheekbones
  • Supplied as a 3 ml syringe filled with 2 ml of gel, with two sterile 30G 13 mm needles
  • Manufactured by Caregen Co., Ltd. (South Korea); CE-marked, single use only
主な情報
ブランド AQUASHINE
製造元 Caregen Co., Ltd.
原産国 South Korea
認証 CE marked (per MDD 93/42/EEC)
成分 Cross-linked sodium hyaluronate 15 mg/ml (1.5%); sodium chloride 6.1 mg/ml; sodium hydroxide 2.7 mg/ml; monosodium phosphate 0.8 mg/ml; disodium phosphate 1.4 mg/ml; sodium bisulfate monohydrate 1.9 mg/ml; 1,4-butanediol diglycidyl ether (BDDE) 0.000021 mg/ml (residual below 1 ppm); protein 0.00046 mg/ml; water for injection to 1.0 ml
容量 / サイズ 2 ml
包装 1 x 2 mL
針のサイズ 30G (0.30 x 13 mm)
使用タイプ For professional use: intradermal hyaluronic acid implant, administered only by qualified practitioners trained in injection technique
注入の深さ Middle and superficial dermis
プロトコル / 期間 Usually one treatment course, occasionally two; aesthetic effect retained 1 to 6 months

適応と専門的な使用

主な適応

  • Correction of wrinkles and folds of the facial tissues
  • Restoration and modelling of volume, and replenishment of missing tissue volume
  • Restoration of the skin's hydrobalance and tissue structure
  • Correction of the shape and volume of the lips, cheekbones and facial oval
  • Rejuvenation of the hands
  • Hydration and rejuvenation of the skin

専門的な使用

Aquashine HA is intended for administration only by qualified medical personnel trained in intradermal injection technique, using aseptic technique. It is placed in the middle and superficial dermis using the supplied 30G (0.30 x 13 mm) needle, by linear (threading), linear-point, point or grid technique. It must not be combined with implants or gels from other manufacturers in a single procedure; injection into the eyelids and intravascular injection are strictly prohibited. Single use, one patient only; do not re-sterilise. Patient selection, injection technique and aftercare remain the responsibility of the treating practitioner.

施術部位

  • Nasolabial folds
  • Oral-chin (labiomental) folds
  • Chin
  • Cheekbones

対象となる患者

Suitable for adult patients seeking correction of wrinkles and folds, restoration of hydrobalance and dermal structure, and rejuvenation of the skin, as assessed by a qualified practitioner. Contraindicated in pregnancy and lactation, allergy to any component, systemic retinoid, anticoagulant/antithrombotic or immunosuppressive therapy, inflammatory infiltrates, progressive chronic dermatoses, herpetic infection, paraneoplastic processes at the injection site, and decompensated severe somatic disease. In patients under 18, only with the consent of a legal representative.

作用の仕組み: Aquashine HA ​

Aquashine HA is a cross-linked hyaluronic acid gel at 15 mg/ml of sodium hyaluronate in a phosphate buffer. Placed in the middle and superficial dermis, the cross-linked hyaluronic acid binds water in the tissue, so the effect is restored moisture, improved dermal density and smoothing of wrinkles and folds rather than deep volumising. Full resorption occurs at approximately one month, with the aesthetic effect retained from one to six months depending on the skin, the wrinkle and the technique used.

Allparaで注文する理由

Allparaは、正規品で検証済みの AQUASHINE 製品を、完全なロットトレーサビリティ、CE認証在庫、EU全域への迅速な配送、専門的なアフターサポートとともに提供しています。

よくある質問

What is in Aquashine HA?

Cross-linked sodium hyaluronate at 15 mg/ml in a phosphate buffer, of non-animal biosynthetic origin, cross-linked with BDDE (residual BDDE below 1 ppm).

Where is Aquashine HA injected?

Into the middle and superficial dermis, using the supplied 30G 13 mm needle. It is directed at the nasolabial and oral-chin folds, the chin and the cheekbones.

How does Aquashine HA differ from Aquashine HA BR?

Aquashine HA is the 15 mg/ml, medium-viscosity variant (25.0 Pa·s), directed at the nasolabial and oral-chin folds, the chin and the cheekbones. Aquashine HA BR is the 13 mg/ml, lower-viscosity variant (18.0 Pa·s), directed at the periorbital zone, neck, lips and forehead.

その他の製品: Caregen

ラボを見る →
* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.